Journal of virology

HBZ stimulates brain-derived neurotrophic factor/TrkB autocrine/paracrine signaling to promote survival of human T-cell leukemia virus type 1-Infected T cells.

PMID 25210182


Brain-derived neurotrophic factor (BDNF) is a neurotrophin that promotes neuronal proliferation, survival, and plasticity. These effects occur through autocrine and paracrine signaling events initiated by interactions between secreted BDNF and its high-affinity receptor, TrkB. A BDNF/TrkB autocrine/paracrine signaling loop has additionally been implicated in augmenting the survival of cells representing several human cancers and is associated with poor patient prognosis. Adult T-cell leukemia (ATL) is a fatal malignancy caused by infection with the complex retrovirus human T-cell leukemia virus type 1 (HTLV-1). In this study, we found that the HTLV-1-encoded protein HBZ activates expression of BDNF, and consistent with this effect, BDNF expression is elevated in HTLV-1-infected T-cell lines compared to uninfected T cells. Expression of TrkB is also higher in HTLV-1-infected T-cell lines than in uninfected T cells. Furthermore, levels of both BDNF and TrkB mRNAs are elevated in peripheral blood mononuclear cells (PBMCs) from ATL patients, and ATL patient sera contain higher concentrations of BDNF than sera from noninfected individuals. Finally, chemical inhibition of TrkB signaling increases apoptosis in HTLV-1-infected T cells and reduces phosphorylation of glycogen synthase kinase 3β (GSK-3β), a downstream target in the signaling pathway. These results suggest that HBZ contributes to an active BDNF/TrkB autocrine/paracrine signaling loop in HTLV-1-infected T cells that enhances the survival of these cells. Infection with human T-cell leukemia virus type 1 (HTLV-1) can cause a rare form of leukemia designated adult T-cell leukemia (ATL). Because ATL patients are unresponsive to chemotherapy, this malignancy is fatal. As a retrovirus, HTLV-1 integrates its genome into a host cell chromosome in order to utilize host factors for replication and expression of viral proteins. However, in infected cells from ATL patients, the viral genome is frequently modified to block expression of all but a single viral protein. This protein, known as HBZ, is therefore believed to modulate cellular pathways necessary for the leukemic state and the chemotherapeutic resistance of the cell. Here we provide evidence to support this hypothesis. We found that HBZ promotes a BDNF/TrkB autocrine/paracrine signaling pathway that is known to enhance the survival and chemotherapeutic resistance of other types of cancer cells. It is possible that inhibition of this pathway may improve treatments for ATL.

Related Materials

Product #



Molecular Formula

Add to Cart

ANA-12, ≥98% (HPLC)
Anti-Actin Antibody, near a.a. 50-70, clone C4, 100 µg, This Anti-Actin Antibody, near a.a. 50-70, clone C4 is validated for use in ELISA, IC, IH, IH(P), WB for the detection of Actin and has published in over 70 citations.
Anti-Myc Tag Antibody, clone 4A6, 200 µg, This Anti-Myc Tag Antibody, clone 4A6 is validated for use in ChIP, IC, IF, IP, WB for the detection of Myc Tag. This antibody has been cited in more than 25 published papers.
Anti-Pyk2 Antibody, 250 µg, This Anti-Pyk2 Antibody is validated for use in IC, IP, WB for the detection of Pyk2.
Anti-NTRK2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Anti-TrkB (Ab-705) antibody produced in rabbit, affinity isolated antibody
T1941 Anti-TrkB antibody produced in goat, affinity isolated antibody, lyophilized powder
K-252a, from Nocardiopsis sp., ≥96.0% (HPLC)
K-252a, from Nocardiopsis sp.
K-252a, from Nonomuraea longicatena, ≥98% (HPLC)
K-252a, Ready Made Solution, from Nonomuraea longicatena, >98%
Monoclonal Anti-NTRK2 antibody produced in mouse, clone 4D3-F10, purified immunoglobulin, buffered aqueous solution
Monoclonal Anti-NTRK2 antibody produced in mouse, clone 3D12, purified immunoglobulin, buffered aqueous solution